Mulder, ChristiaanRupert, StephanSetiawan, EryMambetova, ElmiraEdo, PatienceSugiharto, JhonUseni, SaniMalhotra, ShellyCook-Scalise, SarahPambudi, ImranKadyrov, AbdullaatLawanson, Adebolavan den Hof, SusanGebhard, AgnesJuneja, SandeepSohn, Hojoon2022-01-102022-01-102022-01-102059-79083499207710.1136/bmjgh-2021-007182http://hdl.handle.net/10029/625508en© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.health economicstreatmenttuberculosisBudgetary impact of using BPaL for treating extensively drug-resistant tuberculosis.ArticleBMJ global health 2022;7(1):e007182